title: SH2B1beta adaptor is a key enhancer of RET tyrosine kinase signaling.
abstract: The RET gene encodes two main isoforms of a receptor tyrosine kinase (RTK) implicated in various human diseases. Activating germ-line point mutations are responsible for multiple endocrine neoplasia type 2-associated medullary thyroid carcinomas, inactivating germ-line mutations for Hirschsprung's disease, while somatic rearrangements (RET/PTCs) are specific to papillary thyroid carcinomas. SH2B1beta, a member of the SH2B adaptors family, and binding partner for several RTKs, has been recently described to interact with proto-RET. Here, we show that both RET isoforms and its oncogenic derivatives bind to SH2B1beta through the SRC homology 2 (SH2) domain and a kinase activity-dependent mechanism. As a result, RET phosphorylates SH2B1beta, which in turn enhances its autophosphorylation, kinase activity, and downstream signaling. RET tyrosine residues 905 and 981 are important determinants for functional binding of the adaptor, as removal of both autophosphorylation sites displaces its recruitment. Binding of SH2B1beta appears to protect RET from dephosphorylation by protein tyrosine phosphatases, and might represent a likely mechanism contributing to its upregulation. Thus, overexpression of SH2B1beta, by enhancing phosphorylation/activation of RET transducers, potentiates the cellular differentiation and the neoplastic transformation thereby induced, and counteracts the action of RET inhibitors. Overall, our results identify SH2B1beta as a key enhancer of RET physiologic and pathologic activities.
authors.affiliation: Department of Experimental Oncology, Research Unit no. 3, Milan, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Donatello
authors.forename: A
authors.initials: A
authors.lastname: Fiorino
authors.forename: D
authors.initials: D
authors.lastname: Degl'Innocenti
authors.forename: L
authors.initials: L
authors.lastname: Alberti
authors.forename: C
authors.initials: C
authors.lastname: Miranda
authors.forename: L
authors.initials: L
authors.lastname: Gorla
authors.forename: I
authors.initials: I
authors.lastname: Bongarzone
authors.forename: M G
authors.initials: MG
authors.lastname: Rizzetti
authors.forename: M A
authors.initials: MA
authors.lastname: Pierotti
authors.forename: M G
authors.initials: MG
authors.lastname: Borrello
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000502:physiology*; D000818:Animals; D002454:Cell Differentiation; D045744:Cell Line, Tumor; D002471:Cell Transformation, Neoplastic; D002478:Cells, Cultured; D006801:Humans; D051379:Mice; D010766:Phosphorylation; D020033:Protein Isoforms / Q000502:physiology; D051096:Proto-Oncogene Proteins c-ret / Q000378:metabolism*; D051381:Rats; D015398:Signal Transduction; D013964:Thyroid Neoplasms / Q000378:metabolism; D018909:src Homology Domains / Q000502:physiology
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D020033:Protein Isoforms; C518910:SH2B1 protein, human; D051096:Proto-Oncogene Proteins c-ret; C099282:RET protein, human